GlobeNewswire by notified

CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS

Share
Anbudsförfarande kommuner och regioner, 2022-01-18
BondsFloating-rate Notes(FRN) issued in SEK by Municipalities or Regions with maturity in:

2024

The following issuers are accepted for delivery:

Borås Stad

Göteborgs Stad

Helsingborgs Stad

Huddinge Kommun

Lunds Kommun

Malmö Stad

Nacka Kommun

Norrköpings Kommun

Region Skåne

Stockholms Stad

Region Stockholm

Sundsvalls Kommun

Södertälje Kommun

Täby Kommun

Uppsala Kommun

Vellinge Kommun

Västerås Stad

Örebro Kommun

Östersunds Kommun




Delivery may not be made in Bonds purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Specific terms, i.e. the purchase may not have been made after:

2022-01-07
BidsBids are made to tel 08-696 69 70 and confirmed in writing by a filled-in Bid form by e-mail to EOL@riksbank.se


Bid date2022-01-18
Bid times10.00-11.00 (CET/CEST) on the Bid date
Requested volume (corresponding nominal amount)SEK 750 +/- 750 million
Highest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 750 million.




No bid may contain Bonds exceeding SEK 750 million issued by Stockholms Stad, Region Stockholm (Stockholms läns landsting) or Göteborgs Stad.




For other issuers, bids may not contain Bonds exceeding SEK 100 million issued by the same issuer.
Lowest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty should not be less than SEK 50 million and not be less than SEK 5 million per Bond (ISIN code).
Credit rating classesThe requested volume is divided into two credit rating classes. Credit rating refers to the issuer’s credit rating. If there are credit ratings from several credit rating agencies the highest of these will be applied.




Class 1: A long-term credit rating of AAA with S&P, Aaa with Moody’s or AAA with Fitch.




Class 2: A long-term credit rating of AA+ with S&P, Aa1 with Moody’s or AA+ with Fitch.
MaturityBonds maturing between January 1. 2024 and December 31. 2024. The year is divided into four quarters and bids are placed for each quarter and Credit Class.




Example: For Credit Class 1 with maturity quarter 2, a bid of SEK 90 million is placed at interest x %.
Expected allocation timeNot later than 11.30 (CET/CEST) on the Bid date
Delivery and payment date2022-01-20
Delivery of bondsBonds issued in the PM section:

To the Riksbank's account in Euroclear Sweden AB's securities settlement system: 1 4948 6383.




Bonds issued in the AM section:

To the Riksbank's account at the Global Custodian State Street:




Global Custodian BIC Code: SBOSUS3CXXX

Local Settlement Agent: SKANDINAVISKA ENSKILDA BANKEN AB (SEB)

Local Settlement Agent BIC Code: ESSESESSXXX

Global Custodian's Account Name at SEB: STATE STREET BANK & TRUST

Global Custodian's Account Number at SEB: 01-100 386 491

Riksbank's Account Name at the Global Custodian: SVERIGES RIKSBANK Riksbank's Account Number at the Global Custodian: 0145

PSET BIC: VPCSSESSXXX




Counterparties must use BIC: ESSESESSXXX in field 95P::DEAG/REAG and State Street BIC: SBOSUS3CXXX in field 95P::SELL/BUYR in the settlement instruction.




Bonds issued for the euro market (ISIN code with XS):

To the Riksbank's account at Euroclear Bank: 91181.


General terms and conditionsGeneral terms and conditions for the Riksbank´s purchases of bonds via bid procedures 2020:3. dated 20 November 2020 (see the Riksbank´s web).

Stockholm, 2022-01-14

This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Fortuna reports financial results for the first quarter of 20248.5.2024 04:11:05 CEST | Press release

(All amounts are expressed in US dollars, tabular amounts in millions, unless otherwise stated) VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) (“Fortuna” or the “Company”) today reported its financial and operating results for the first quarter of 2024. First Quarter 2024 highlights Financial Attributable net income of $26.3 million or $0.09 per share, compared to a $92.3 million attributable net loss or $0.30 per share in Q4 2023Adjusted attributable net income1 of $26.7 million or $0.09 per share, compared to $20.6 million or $0.07 per share in Q4 2023Generated $84.3 million of cash flow from operations before working capital changes, and free cash flow from ongoing operations1 of $12.1 million, compared to $105.4 million and $66.2 million, respectively, in Q4 2023The Company paid down $40.0 million of its revolving credit facility. At the close of the quarter total net debt was $83.0 million and the total net debt to ad

GXO Reports First Quarter 2024 Results7.5.2024 22:30:00 CEST | Press release

First quarter revenue of $2.5 billion, up 6% year over year; organic revenue growth1 of 1%Signed new business wins of approximately $250 million in annualized revenue in 1Q 2024; up 55% year over yearSales pipeline at 12-month high of $2.2 billionCompleted acquisition of Wincanton on April 29, 2024 GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2024. Malcolm Wilson, chief executive officer of GXO, said, “We delivered a strong start to 2024, reflecting our solid execution amid improving industry dynamics. The company grew revenue by 6% to $2.5 billion and delivered positive organic revenue growth, while gaining market share. We look forward to driving continued growth throughout 2024 and are on track to achieve our full-year outlook. “We’re seeing strengthening demand from global blue-chip customers to realize operational efficiencies today while planning fulfillment strategies to meet their future needs.

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update7.5.2024 22:30:00 CEST | Press release

Montrouge, France, May 7, 2024 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update VITESSE enrollment on track to screen last patient by Q3 2024Appointment of Robert Pietrusko, PharmD to Chief Regulatory OfficerQ1 2024 closes with a cash balance of $101.5 million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the first quarter 2024. The quarterly financial statements were approved by the Board of Directors on May 7, 2024. Recent Business Developments Clinical and Regulatory Update Enrollment for VITESSE, DBV’s Phase 3 pivotal study of the modified Viaskin Peanut patch in children ages 4 through 7 years with peanut allergy passed the halfway point for recruitment in Q1 and continues to be on track to screen the last patient by

SFL - Invitation to Presentation of Q1 2024 Results7.5.2024 22:19:00 CEST | Press release

SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the first quarter of 2024 on Tuesday, May 14, 2024. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, May 14, 2024, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at www.sflcorp.com. In order to listen to the conference call and presentation, you may do one of the following: A: Join Conference CallWebcast In Listen Only Mode: Visit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to "Webcast", or access directly via the webcast link below. The webcast with slideshow will be played live from this platform: SFL Corporation Ltd. Q1 2024 Webcast B: Join Conference Call AndParticipate in Live Q&AthroughZoom: Join through the Zoom link below to ask a question: SFL Q1 2024 Q&A Meeti

Oculis Publishes Invitation to the Annual General Meeting7.5.2024 22:05:00 CEST | Press release

Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST / 9:30 a.m. EDT. All information pertaining to the 2024 Annual General Meeting, including meeting materials, can be accessed on the Oculis website at https://investors.oculis.com/events-presentations. About Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior

HiddenA line styled icon from Orion Icon Library.Eye